logo
#

Latest news with #Gein

Netflix's 'Monster' Season 3 Digs Into Ed Gein's Horrors After Dahmer, Menendez Brothers
Netflix's 'Monster' Season 3 Digs Into Ed Gein's Horrors After Dahmer, Menendez Brothers

Newsweek

time05-05-2025

  • Entertainment
  • Newsweek

Netflix's 'Monster' Season 3 Digs Into Ed Gein's Horrors After Dahmer, Menendez Brothers

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Netflix's Monster anthology series will return with a third installment that dives into the life and crimes of Ed Gein, the Wisconsin murderer whose gruesome legacy shaped modern horror. Following the success of Dahmer—Monster: The Jeffrey Dahmer Story and Monsters: The Lyle and Erik Menendez Story, creators Ryan Murphy and Ian Brennan will continue their exploration of America's most chilling criminal minds with Monster: The Original Monster, casting Charlie Hunnam as Gein. The new season will not only revisit Gein's crimes but also explore how his story has influenced generations of filmmakers and pop culture, according to TV Insider. Who Is Ed Gein? Gein, one of America's most infamous killers, was born in 1906 in La Crosse, Wisconsin. He was raised on a secluded farm in Plainfield by an alcoholic father and a deeply religious mother who instilled in him the belief that women and sexuality were immoral, according to Following the deaths of his father, brother, and mother between 1940 and 1945, Gein became reclusive, remaining alone on the family farm, reported According to Gein's crimes and his background inspired the creation of Norman Bates in Psycho, Leatherface in The Texas Chain Saw Massacre, and Buffalo Bill in The Silence of the Lambs. Ed Gein is seen at the Wisconsin State Crime Laboratory in Madison on November 19, 1957, for questioning in connection with the slaying of a Plainfield widow. Ed Gein is seen at the Wisconsin State Crime Laboratory in Madison on November 19, 1957, for questioning in connection with the slaying of a Plainfield widow. Edward Kitch/AP Photos What Did Ed Gein Do to His Victims? Gein's criminal actions came to light in 1957 when authorities found the body of Bernice Worden, a missing store clerk, in his farmhouse—decapitated and gutted. Inside, police discovered an array of human remains including skulls, organs, and skin-made items such as lampshades, chairs and a suit. Gein admitted to digging up the graves of recently buried women who, he said, resembled his mother, according to Despite the shocking volume of remains found, Gein was only legally linked to two murders—Worden and Mary Hogan. Declared mentally unfit to stand trial, he was committed to the Mendota Mental Health Institute. In 1968, he was found guilty by reason of insanity and spent the rest of his life institutionalized, dying of cancer in 1984. He was 77 years old. What to Know About Netflix's Monster Season 3 on Ed Gein Season 3 of Monster, officially titled Monster: The Original Monster, will shift focus to Gein, continuing the anthology format started by Murphy and Brennan. Hunnam will portray Gein, joined by Laurie Metcalf as Augusta Gein, Tom Hollander as Alfred Hitchcock, and Olivia Williams as Alma Hitchcock. The show aims to not only recount Gein's crimes but also address his lasting imprint on horror media. The inclusion of characters like Hitchcock, film director of notorious movies including Psycho, could mean that the third season of Monster will touch on broader thematic examination of Gein's influence on Hollywood, TV Insider reported. The Monster series is currently the third-most popular Netflix English language series, according to Netflix's Tudum. The site reported that the first season focusing on Jeffrey Dahmer "reached 1 billion hours of viewing in its first 60 days, making it one of only four series to achieve this milestone." Actor Charlie Hunnam is seen in Los Angeles in August 2011. Actor Charlie Hunnam is seen in Los Angeles in August 2011. Chris Pizzello/AP Photos When Will Netflix's Ed Gein Monster Season 3 Come Out? An exact premiere date has not yet been announced, but Netflix confirmed that filming began in November 2024 in Chicago. Both previous seasons—focusing on Dahmer and the Menendez brothers—debuted in September, suggesting a similar timeline is likely for the Gein-focused season. Given the previous release schedule and current production status, viewers may expect a release sometime in the latter half of 2025. What People are Saying A Reddit user named u/billybumbler posted on May 5: "If I remember correctly, its rumored he probably killed his brother as well. There was a fire on the family farm where his brother had died while trying to put it out along side Ed. Its believed Ed started the fire so trick his brother and then killed him with a blow to the head of some sort. His brother did not fall in line with their mother's extremely religious views, and that caused some anger." A Reddit user named u/Crunchyfrozenoj posted on May 4: "They're currently making a series on him. Charlie Hunnam (who is objectively hot) is playing him. Get ready for the fan girls." A Reddit user named u/Catdaddy84 posted in September: "Very interesting choice, I just watched a documentary about this case. Charlie is very different from Ed but I'm sure they'll make it work."

Monster Season 3: Release date speculation, cast and plot details – Everything we know so far
Monster Season 3: Release date speculation, cast and plot details – Everything we know so far

Business Upturn

time05-05-2025

  • Entertainment
  • Business Upturn

Monster Season 3: Release date speculation, cast and plot details – Everything we know so far

By Aman Shukla Published on May 5, 2025, 17:30 IST Last updated May 5, 2025, 11:30 IST Ryan Murphy's gripping true crime anthology series, Monster , is set to return for a chilling third season on Netflix, diving into the horrifying story of serial killer Ed Gein. Following the success of Season 1 (Jeffrey Dahmer) and Season 2 (The Lyle and Erik Menendez Story), fans are eager for updates on Monster Season 3. Here's everything we know so far about the release date, cast, and plot details. Monster Season 3 Release Date Speculation Netflix has confirmed that Monster Season 3, officially titled The Original Monster , is slated for release in 2025, as revealed in a January 2025 shareholder letter. While an exact date remains unannounced, speculation points to a late summer or fall 2025 premiere, possibly September, aligning with the series' previous release patterns. Filming began on October 31, 2024, suggesting post-production could wrap in time for a 2025 debut. Monster Season 3 Cast: Who's Starring? The cast for Monster Season 3 is stacked with talent, led by Charlie Hunnam as the infamous Ed Gein, known as the 'Butcher of Plainfield.' Hunnam, recognized for his roles in Sons of Anarchy and Pacific Rim , is set to deliver a haunting performance. Joining him are: Laurie Metcalf as Augusta Gein, Ed's domineering mother, whose influence shaped his disturbed psyche. as Augusta Gein, Ed's domineering mother, whose influence shaped his disturbed psyche. Tom Hollander as Alfred Hitchcock, the iconic director whose film Psycho drew inspiration from Gein's crimes. as Alfred Hitchcock, the iconic director whose film drew inspiration from Gein's crimes. Olivia Williams as Alma Reville, Hitchcock's wife and creative collaborator. as Alma Reville, Hitchcock's wife and creative collaborator. Suzanna Son in an undisclosed role, adding fresh talent to the ensemble. in an undisclosed role, adding fresh talent to the ensemble. Addison Rae, reportedly joining the cast, though her role remains unconfirmed. Monster Season 3 Potential Plot Monster Season 3 is expected to explore the life and crimes of Ed Gein, a Wisconsin murderer and body snatcher whose gruesome acts in the 1950s inspired fictional killers like Norman Bates ( Psycho ), Buffalo Bill ( The Silence of the Lambs ), and Leatherface ( The Texas Chain Saw Massacre ). Known for murdering at least two people, desecrating graves, and crafting items from human remains, Gein's story is both horrific and complex. While specific plot details are scarce, the series is likely to balance graphic depictions of Gein's atrocities with a nuanced look at his mental health and isolation, sparking discussions about the ethics of true crime dramatizations. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Ed Gein documentary out today promises 'never-before-heard' details ahead of new Netflix Monsters
Ed Gein documentary out today promises 'never-before-heard' details ahead of new Netflix Monsters

Daily Mirror

time01-05-2025

  • Entertainment
  • Daily Mirror

Ed Gein documentary out today promises 'never-before-heard' details ahead of new Netflix Monsters

It is a must-watch for fans of Netflix's Monsters series Netflix enthusiasts have been on tenterhooks for months as they await updates on the much-anticipated third season of the crime drama series Monsters. The show, co-created by Ryan Murphy, has so far delved into the crimes of Jeffrey Dahmer and the Menendez Brothers, with the notorious 'body snatcher' Ed Gein set to be the next criminal profiled. ‌ The anthology series has been smashing records with each new season. Monster: The Jeffrey Dahmer Story raked in a staggering one billion viewing hours within its first 60 days, while the second instalment, Monsters: The Lyle and Erik Menendez Story, quickly became one of Netflix's most viewed shows of the year. ‌ The series even had real-world repercussions, with the actual Menendez Brothers expressing their gratitude for the show. In an interview with TMZ, they revealed: "Once you bring a spotlight on it, the bullying and the trauma tends to find healing or find recourse and so I feel like shining a light on it now Ryan Murphy did his project ended up doing that and so in that way I think we are grateful." Filming for the upcoming third series, titled The Original Monster, kicked off in November, featuring Charlie Hunman of Sons of Anarchy fame as Ed Gein. While an official release date is yet to be confirmed, it's anticipated to hit screens in late 2025, reports Surrey Live. While fans may have a bit of a wait on their hands, there's no shortage of documentaries exploring the crimes of Ed Gein. In fact, a brand new documentary has just been released, promising to recount the killer's story in a way never seen before. ‌ Psycho: The Lost Tales of Ed Gein is an MGM+ original series released today (May 1). The official synopsis reveals: "This MGM+ original docuseries follows the horrifying grave robber and serial killer Ed Gein whose crimes inspired such iconic films as Psycho and The Silence of the Lambs. "With new reveals and never-before-heard recordings, viewers will be transported to late-1950s Middle America and submerged in Gein's perverse mind. "The series explores Gein's upbringing and twisted relationship with his mother, his early grave robbing and murders, and the police's discovery of his terrifying house of horrors." ‌ Who was Ed Gein? Edward Theodore Gein was born in 1906 in Wisconsin. He was a murderer and suspected serial killer known for his macabre collection of body parts which he crafted into masks, clothing and household items. Among his gruesome collection was a bowl made from a skull and a lampshade made from human skin. He even confessed to wanting to create a wearable woman suit out of skin. Upon investigation, police discovered that Gein had robbed graves to collect the remains. He confessed to two murders but was only ever convicted of one due to being deemed unfit to stand trial by reason of insanity. However, authorities suspect he killed many more. Diagnosed with schizophrenia, Gein spent the rest of his life in a psychiatric institution until his death at the age of 77 in 1984 from complications of lung cancer. He has been credited as the muse for several iconic horror film characters, including Psycho's Norman Bates, Leatherface from The Texas Chainsaw Massacre, and Buffalo Bill from The Silence of the Lambs.

Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

Yahoo

time28-03-2025

  • Business
  • Yahoo

Geovax Labs Inc (GOVX) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...

Release Date: March 27, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Geovax Labs Inc (NASDAQ:GOVX) received a significant Project NextGen Award valued at almost $400 million to support their next-generation COVID-19 vaccine, CMO4S1. The company has completed CGMP product and quality release for their Mpox and smallpox vaccine candidate, GOMVA, with plans for clinical evaluation in the second half of the year. Geovax Labs Inc (NASDAQ:GOVX) is advancing its MVA manufacturing process, which is expected to significantly reduce costs and support decentralized vaccine manufacturing. The company's COVID-19 vaccine, CMO4S1, is designed to address unmet needs among immunocompromised patients and has shown potential for broader use as a booster to current mRNA vaccines. Geovax Labs Inc (NASDAQ:GOVX) is actively pursuing strategic partnerships and collaborations to support worldwide development and commercialization of their vaccines. Geovax Labs Inc (NASDAQ:GOVX) reported a net loss of approximately $25 million for 2024, driven by increased manufacturing activities and costs associated with the BARDA contract. The company's cash balance decreased to $5.5 million at the end of 2024, reflecting significant cash usage in operating activities. There is uncertainty regarding the ability to sell the Mpox vaccine without clinical testing, despite the urgent global need. The start of the next Gein trial has been pushed back to mid to late 2025 due to manufacturing and cell line issues. Geovax Labs Inc (NASDAQ:GOVX) faces challenges in securing equitable vaccine access and manufacturing partnerships in low-income countries, despite ongoing discussions. Warning! GuruFocus has detected 2 Warning Signs with GOVX. Q: Given the urgency of the Mpox threat, could GeoVax Labs potentially sell products without clinical testing, considering the testing is supposed to start around the end of 2025? A: David Dodd, Chairman and CEO, explained that while typically you cannot sell without clinical testing, there is an opportunity through emergency use licensing with WHO. The critical global need, especially in Africa, underscores the importance of additional supply options. GeoVax has produced enough product for clinical needs and additional evaluation, which might lead to revenue generation, but this remains uncertain. Q: How is GeoVax working with international partners and regulatory agencies to ensure equitable vaccine access and manufacturing in low-income countries? A: David Dodd highlighted that equitable vaccine access is a major focus. GeoVax has been in discussions with Africa CDC, European regulatory agencies, and other stakeholders for over a year. They are actively engaging with organizations like UNICEF to support funding and supply chain initiatives. Q: What is needed to start the next Gein trial, and is there a timeline for enrollment? A: David Dodd stated that they are continuing to manufacture the product and have faced some issues with the cell line. Clinical trial operations are outlined, and investigators are identified. The trial is expected to initiate in the mid to latter part of next year, with a focus on having sufficient product supply. Q: How will GeoVax test the efficacy and safety of the MVA vaccine, given it's a preventive vaccine? A: Dr. John Sharkey, VP of Business Development, explained that efficacy is typically tested in nonhuman primates, but discussions with regulators are ongoing about potentially using lower animals. Any required animal studies could run parallel to clinical trials, minimizing impact on trial timelines. Q: With the uncertainty in Washington regarding COVID-19 funding, how might this affect GeoVax's BAA Project NextGen trial? A: David Dodd noted that despite uncertainties, GeoVax maintains regular communication with BARDA, and the project continues as planned. There have been no directives to slow down, and the focus remains on starting the clinical trial by year-end, with all necessary preparations underway. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store